In mouse models, inhibition of CD38 restricted primary tumor growth and was associated with lower rates of pulmonary and brain metastasis as a result of promoted cell death, reduction in cancer-associated fibroblast, and prevention of angiogenesis. The gene discussed is CD38; the disease is cancer.